Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of CD133+
CD54+
CD44+
circulating tumor cells in colorectal cancer with liver metastasis
Authors
Keywords
-
Journal
Cancer Medicine
Volume 6, Issue 12, Pages 2850-2857
Publisher
Wiley
Online
2017-11-03
DOI
10.1002/cam4.1241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer
- (2013) Brenda K. Edwards et al. CANCER
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Circulating Tumor Cells
- (2013) V. Plaks et al. SCIENCE
- Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies
- (2013) C-W Fan et al. Cell Death & Disease
- Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
- (2012) C. Aggarwal et al. ANNALS OF ONCOLOGY
- CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
- (2012) Shan-shan Zhang et al. BMC Medicine
- Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992-2008
- (2012) R. L. Siegel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CD133+, CD166+CD44+, and CD24+CD44+ Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell Lines
- (2012) Manuele Giuseppe Muraro et al. Stem Cells Translational Medicine
- Circulating tumor cells: approaches to isolation and characterization
- (2011) Min Yu et al. JOURNAL OF CELL BIOLOGY
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Clinical Significance of CEA and CA19-9 in Postoperative Follow-up of Colorectal Cancer
- (2010) Tomomi Yakabe et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
- (2010) Roberta Pang et al. Cell Stem Cell
- Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
- (2009) Brenda K. Edwards et al. CANCER
- Cancer micrometastases
- (2009) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases
- (2008) Hyuk Hur et al. AMERICAN JOURNAL OF SURGERY
- CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells
- (2008) Naotsugu Haraguchi et al. ANNALS OF SURGICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started